HK1057542A1 - Intermediates in cephalosporin production - Google Patents

Intermediates in cephalosporin production

Info

Publication number
HK1057542A1
HK1057542A1 HK03108285.4A HK03108285A HK1057542A1 HK 1057542 A1 HK1057542 A1 HK 1057542A1 HK 03108285 A HK03108285 A HK 03108285A HK 1057542 A1 HK1057542 A1 HK 1057542A1
Authority
HK
Hong Kong
Prior art keywords
intermediates
cephalosporin production
cephalosporin
production
Prior art date
Application number
HK03108285.4A
Other languages
English (en)
Inventor
Peter Kremminger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HK1057542A1 publication Critical patent/HK1057542A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D501/06—Acylation of 7-aminocephalosporanic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK03108285.4A 2000-09-11 2003-11-13 Intermediates in cephalosporin production HK1057542A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0153700A AT411996B (de) 2000-09-11 2000-09-11 Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
PCT/EP2001/010447 WO2002020532A1 (en) 2000-09-11 2001-09-10 Intermediates in cephalosporin production

Publications (1)

Publication Number Publication Date
HK1057542A1 true HK1057542A1 (en) 2004-04-08

Family

ID=3688325

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108285.4A HK1057542A1 (en) 2000-09-11 2003-11-13 Intermediates in cephalosporin production

Country Status (13)

Country Link
US (1) US6894162B2 (de)
EP (1) EP1319009B1 (de)
JP (1) JP2004508378A (de)
KR (1) KR100864405B1 (de)
CN (1) CN1200941C (de)
AT (2) AT411996B (de)
AU (1) AU2001287725A1 (de)
CA (1) CA2419258C (de)
DE (1) DE60136285D1 (de)
DK (1) DK1319009T3 (de)
HK (1) HK1057542A1 (de)
TW (1) TWI282339B (de)
WO (1) WO2002020532A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190849B (de) * 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
US20040092735A1 (en) * 2002-11-08 2004-05-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefuroxime sodium
WO2004050663A2 (en) * 2002-12-05 2004-06-17 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of cefuroxime sodium
US7662955B2 (en) * 2003-03-20 2010-02-16 Orchid Chemicals And Pharmaceuticals Ltd. Process for the preparation of cefoxitin
EP1863822B1 (de) * 2005-03-29 2009-10-14 Hetero Drugs Limited Verbessertes verfahren zur herstellung von cefixim
ITMI20050871A1 (it) 2005-05-13 2006-11-14 Acs Dobfar Spa Solvato cristallino di cefuroxima acido
CN104961749B (zh) * 2015-06-15 2016-01-13 海南灵康制药有限公司 一种头孢呋辛钠的新型工业结晶方法及其制剂
CN105440052A (zh) * 2016-01-13 2016-03-30 广东立国制药有限公司 一种头孢呋辛酸的制备方法
CN106554361B (zh) * 2016-09-30 2018-10-09 华北制药河北华民药业有限责任公司 一种头孢呋辛酯口服制剂的制备方法
CN112745338B (zh) * 2020-12-30 2022-08-16 山东金城昆仑药业有限公司 消除头孢呋辛酸中内酯杂质的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US391589A (en) * 1888-10-23 Variety wood-worker
GB1474519A (de) * 1973-05-14 1977-05-25
US4122259A (en) * 1974-08-23 1978-10-24 Glaxo Laboratories Limited 7β-[2-Aryl-2-(etherified oximino)acetamido]-3-N-substituted carbamoyloxymethylceph-3-em-4-carboxylic acids
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1575905A (en) * 1976-04-28 1980-10-01 Glaxo Lab Ltd Salt of cefuroxime
GB2018764B (en) * 1978-04-07 1982-09-02 Glaxo Group Ltd Cephalosporin compounds
DE2937951A1 (de) * 1978-09-21 1980-04-17 Glaxo Group Ltd Verfahren zur herstellung von cephalosporinverbindungen
SE451724B (sv) * 1979-02-15 1987-10-26 Glaxo Group Ltd Forfarande for framstellning av natriumcefuroxim
DE2938065A1 (de) * 1979-04-06 1980-10-16 Glaxo Group Ltd Verfahren zur herstellung von cephalosporinverbindungen
DK165118C (da) 1980-11-22 1993-03-01 Gema Sa Fremgangsmaade til fremstilling af oploesninger af 7-aminocephalosporansyrer
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
ES522728A0 (es) 1983-05-26 1985-06-01 Gema Sa "sales de acidos amino-beta-lactamicos, para su aplicacion a la obtencion de n-acil derivados de los mismos, y procedimiento para la obtencion de dichas sales"
GB8320521D0 (en) 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
IT1214587B (it) * 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.
PL151670B1 (pl) * 1987-03-19 1990-09-28 Sposób otrzymywania półsyntetycznych cefalosporyn
JP3121903B2 (ja) 1992-02-07 2001-01-09 塩野義製薬株式会社 デアセチルセファロスポラン酸のカルバモイル化方法
AT400717B (de) 1993-07-30 1996-03-25 Biochemie Gmbh Neue guanidin- und amidinsalze von 7-amino-3- hydroxymethyl-3-cephem-4-carbonsäure
WO2000053609A1 (en) 1999-03-09 2000-09-14 Ranbaxy Laboratories Limited Process for the preparation of cefuroxime
IT1313569B1 (it) 1999-07-27 2002-09-09 Antibioticos Spa Processo per la sintesi di derivati beta-lattamici.
IN190849B (de) * 2000-07-17 2003-08-23 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
WO2002020532A1 (en) 2002-03-14
KR100864405B1 (ko) 2008-10-20
US6894162B2 (en) 2005-05-17
ATA15372000A (de) 2004-01-15
TWI282339B (en) 2007-06-11
KR20030040404A (ko) 2003-05-22
AU2001287725A1 (en) 2002-03-22
EP1319009B1 (de) 2008-10-22
DK1319009T3 (da) 2009-02-16
CA2419258C (en) 2009-12-29
EP1319009A1 (de) 2003-06-18
DE60136285D1 (de) 2008-12-04
CA2419258A1 (en) 2002-03-14
AT411996B (de) 2004-08-26
JP2004508378A (ja) 2004-03-18
CN1454212A (zh) 2003-11-05
US20030171577A1 (en) 2003-09-11
CN1200941C (zh) 2005-05-11
ATE412001T1 (de) 2008-11-15

Similar Documents

Publication Publication Date Title
IL184144A0 (en) Intermediates useful in the preparaiton of 2-aminocarbonyl-9h-purine derivatives
HK1050007A1 (en) Novel biarylcarboxamides
AU8860401A (en) Novel guanidinobenzamides
EP1254211A4 (de) Herstellung von zellen
GB0000185D0 (en) Ethanol production
AU1217102A (en) Novel arylalkane-sulfonamides
HK1057542A1 (en) Intermediates in cephalosporin production
IL153471A0 (en) Novel arylethene-sulfonamides
AU2028402A (en) Bioproduct production
GB2378551B (en) Form production system
HUP0101573A3 (en) Mould
AU2408802A (en) Novel carbapenem derivatives
GB0009630D0 (en) Ferroalloy production
GB0019234D0 (en) Therapeutics
AU2002333294A1 (en) Intermediates in cephalosporin production
GB0022992D0 (en) Novel vompounds
GB0110924D0 (en) Decorative aid
PL341633A1 (en) Structural shape
GB0015574D0 (en) Foam production
GB0003927D0 (en) J H L wheel-safe
GB0025883D0 (en) Ferroalloy production
GB0018354D0 (en) Ferroalloy production
PL110575U1 (en) Shape
PL111719U1 (en) Shape
PL111715U1 (en) Shape

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: SANDOZ AG

Free format text: FORMER OWNER(S): SANDOZ GMBH

CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120910